✦ LIBER ✦

P.2.d.019 Asenapine in the treatment of bipolar 1 disorder: a 12 months study

✍ Scribed by Fernandez Galvez, A.; Romero Guillena, S.L.; Dominguez Ballesteros, M.E.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.2.d.019 Treatment adherence in bipolar

✍ Murgulescu, A.M.; Marinescu, V. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 58 KB

P.2.d.047 Efficacy and safety of asenapi

✍ Di Nicola, M.; De Vita, O.; Pettorruso, M.; De Risio, L.; Marconi, M.; Bruschi, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 78 KB

P.2.e.019 Predictors of recurrence in bi

✍ A. Mrad; L. Bouzgarrou; A. Mechri; W. Douki; M.F. Najjar; L. Gaha 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 105 KB

P.2.e.012 Treatment of mania in bipolar

✍ R. McIntyre; J. Panagides; L. Alphs; M. Cohen; S. Lancaster; T. Macek 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Efficacy and tolerability of quetiapine

✍ A.C. Altamura; Daniele Salvadori; Donato Madaro; Annalisa Santini; Emanuela Mund 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 50 KB

P.2.d.041 The benefit of physical activi

✍ Oberreither, E.; Bengesser, S.; Lackner, N.; Fellendorf, F.; Mitteregger, A.; Ka 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 77 KB